The Food and Drug Administration (FDA) has updated regulations to reflect the withdrawal of approval for seven new animal drug applications due to non-compliance with reporting requirements. This change means that certain firms are no longer recognized as sponsors for these drugs. The decision takes effect on February 23, 2021, and involves technical amendments to various parts of the Code of Federal Regulations to ensure accuracy. The rule does not impose any new burdens on businesses and is not subject to further review or certain regulatory requirements.
Simple Explanation
The FDA took away permission for some medicines made for animals because the companies didn’t follow all the rules about telling the FDA how the medicines were working. This means the medicines might not be available from those companies anymore.